Get started
Author

Stefan Rudziński

Observed institution: Medical University of Warsaw
ORCID: 0000-0002-1122-5796
Observed ORCID: 0000-0002-1122-5796
OpenAlex ID: A5068565157
Allogenic Adipose-Derived Stem Cells in Diabetic Foot Ulcer Treatment: Clinical Effectiveness, Safety, Survival in the Wound Site, and Proteomic Impact
2023 · Beata Mrozikiewicz-Rakowska, Ilona Szabłowska-Gadomska, et al. · International Journal of Molecular Sciences · 27
PDF
The Potential of Mesenchymal Stem/Stromal Cells in Diabetic Wounds and Future Directions for Research and Therapy—Is It Time for Use in Everyday Practice?
2024 · Damian Sieńko, Ilona Szabłowska-Gadomska, et al. · International Journal of Molecular Sciences · 12
PDF
Secretome of Mesenchymal Stromal Cells as a Possible Innovative Therapeutic Tool in Facial Nerve Injury Treatment
2023 · Ilona Szabłowska-Gadomska, Stefan Rudziński, et al. · BioMed Research International · 8
PDF
Biologically Active Sheep Colostrum for Topical Treatment and Skin Care
2024 · Kinga Kazimierska, Ilona Szabłowska-Gadomska, et al. · International Journal of Molecular Sciences · 4
Donor Variability and Stromal Vascular Fraction Isolation Outcomes: Implications for Adipose Tissue-Derived ATMP Manufacturing
2026 · Ilona Szabłowska-Gadomska, Stefan Rudziński, et al. · Preprints.org
Expansion medium shapes molecular profiles of adscs: implications for the development of future cell-based medicinal products.
2026 · Ilona Szabłowska-Gadomska, Monika Sapeta-Nowińska, et al. · Figshare
Alterations in Immunomodulatory Potential of ADSCs Undergoing Osteogenic Differentiation in the Context of Future Therapeutic Applications
2026 · Ilona Szabłowska-Gadomska, Stefan Rudziński, et al. · Cells
PDF
Works count: 7
Citation count: 51
H-index: 4
I10-index: 2
Year
Topic
Type